ATE173727T1 - Substituierte chinoline für die behandlung von leismaniosen - Google Patents
Substituierte chinoline für die behandlung von leismaniosenInfo
- Publication number
- ATE173727T1 ATE173727T1 AT92921565T AT92921565T ATE173727T1 AT E173727 T1 ATE173727 T1 AT E173727T1 AT 92921565 T AT92921565 T AT 92921565T AT 92921565 T AT92921565 T AT 92921565T AT E173727 T1 ATE173727 T1 AT E173727T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- alkyl
- alkenyl
- phenyl
- pct
- Prior art date
Links
- 229940111121 antirheumatic drug quinolines Drugs 0.000 title abstract 2
- 150000003248 quinolines Chemical class 0.000 title abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- -1 methylenedioxyphenyl Chemical group 0.000 abstract 3
- 125000003368 amide group Chemical group 0.000 abstract 2
- 125000005805 dimethoxy phenyl group Chemical group 0.000 abstract 2
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 abstract 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 1
- 125000005741 alkyl alkenyl group Chemical group 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 150000005846 sugar alcohols Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9112174A FR2682107B1 (fr) | 1991-10-03 | 1991-10-03 | Quinoleines 2-substituees pour le traitement des leishmanioses. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE173727T1 true ATE173727T1 (de) | 1998-12-15 |
Family
ID=9417546
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92921565T ATE173727T1 (de) | 1991-10-03 | 1992-09-29 | Substituierte chinoline für die behandlung von leismaniosen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5541196A (de) |
| EP (1) | EP0606380B1 (de) |
| JP (1) | JP3728627B2 (de) |
| AT (1) | ATE173727T1 (de) |
| DE (1) | DE69227695D1 (de) |
| ES (1) | ES2127762T3 (de) |
| FR (1) | FR2682107B1 (de) |
| GR (1) | GR3029471T3 (de) |
| OA (1) | OA09930A (de) |
| WO (1) | WO1993007125A1 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2819507B1 (fr) | 2001-01-17 | 2007-09-28 | Inst Rech Developpement Ird | Quinoleines substituees pour le traitement de co-infections a protozoaires et a retrovirus |
| US6673351B1 (en) | 2001-03-16 | 2004-01-06 | Astralis, Llc | Compositions and methods for the treatment and clinical remission of psoriasis |
| US20040241168A1 (en) * | 2001-03-16 | 2004-12-02 | O'daly Jose A. | Compositions and methods for the treatment and clinical remission of psoriasis |
| US9321730B2 (en) * | 2007-08-21 | 2016-04-26 | The Hong Kong Polytechnic University | Method of making and administering quinoline derivatives as anti-cancer agents |
| US9493419B2 (en) | 2007-08-21 | 2016-11-15 | The Hong Kong Polytechnic University | Quinoline derivatives as anti-cancer agents |
| FR2929943B1 (fr) * | 2008-04-15 | 2010-09-24 | Inst Rech Developpement Ird | Sels de quinoleines 2-substituees |
| FR2931479B1 (fr) * | 2008-05-20 | 2012-12-07 | I R D | Nouveaux derives de quinoleines 2-substituees et un procede pour leur preparation |
| MX2016004464A (es) * | 2013-10-10 | 2017-01-12 | Univ Leuven Kath | Derivados novedosos de pradimicina para el tratamiento de enfermedades provocadas por kinetoplastidos. |
| US11129824B2 (en) | 2015-12-17 | 2021-09-28 | Biokine Therapeutics Ltd. | Small molecules for inhibiting chemokine activity and/or cancer cells growth |
| WO2020206252A1 (en) * | 2019-04-03 | 2020-10-08 | University Of Central Florida Research Foundation, Inc. | Antimalarial compounds |
| AU2020276793A1 (en) | 2019-05-15 | 2022-01-20 | Alonbio Ltd. | Small molecules for treating cancer, inhibiting chemokine activity and/or inducing cell death |
| CN110229101B (zh) * | 2019-05-31 | 2020-11-03 | 浙江工业大学 | 用于检测黏度的aie荧光化合物及其制备与应用 |
| CN115209883B (zh) * | 2020-01-20 | 2025-05-20 | 新月生物科学 | 新型细胞代谢调节化合物及其用途 |
| JP2023532888A (ja) | 2020-06-27 | 2023-08-01 | クレセンタ バイオサイエンシズ | 細胞代謝を調節する化合物の組成及び使用方法 |
| US12138243B2 (en) | 2021-12-31 | 2024-11-12 | Crescenta Biosciences | Antiviral use of FABP4 modulating compounds |
| WO2025091990A1 (zh) * | 2023-10-30 | 2025-05-08 | 湖北工程学院 | 一种壳聚糖铜MOF材料及其应用、β-硼亚胺化合物和羟基化合物的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3636216A (en) * | 1968-09-26 | 1972-01-18 | Salsbury Lab | Coccidiosis control with quinalinol derivatives |
| US4209519A (en) * | 1978-03-13 | 1980-06-24 | The United States Of America As Represented By The Secretary Of The Army | Anti-leishmanial lepidine derivatives |
| GT198900005A (es) * | 1988-01-29 | 1990-07-17 | Quinolinas y cinolinas substituidas. |
-
1991
- 1991-10-03 FR FR9112174A patent/FR2682107B1/fr not_active Expired - Lifetime
-
1992
- 1992-09-29 DE DE69227695T patent/DE69227695D1/de not_active Expired - Lifetime
- 1992-09-29 AT AT92921565T patent/ATE173727T1/de not_active IP Right Cessation
- 1992-09-29 WO PCT/FR1992/000903 patent/WO1993007125A1/fr not_active Ceased
- 1992-09-29 EP EP92921565A patent/EP0606380B1/de not_active Expired - Lifetime
- 1992-09-29 JP JP50665193A patent/JP3728627B2/ja not_active Expired - Lifetime
- 1992-09-29 ES ES92921565T patent/ES2127762T3/es not_active Expired - Lifetime
- 1992-09-29 US US08/211,239 patent/US5541196A/en not_active Expired - Lifetime
-
1994
- 1994-03-30 OA OA60489A patent/OA09930A/fr unknown
-
1999
- 1999-02-24 GR GR990400568T patent/GR3029471T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0606380B1 (de) | 1998-11-25 |
| DE69227695D1 (de) | 1999-01-07 |
| GR3029471T3 (en) | 1999-05-28 |
| JPH07501048A (ja) | 1995-02-02 |
| ES2127762T3 (es) | 1999-05-01 |
| FR2682107A1 (fr) | 1993-04-09 |
| FR2682107B1 (fr) | 1995-04-21 |
| US5541196A (en) | 1996-07-30 |
| EP0606380A1 (de) | 1994-07-20 |
| WO1993007125A1 (fr) | 1993-04-15 |
| OA09930A (fr) | 1994-11-15 |
| JP3728627B2 (ja) | 2005-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69227695D1 (de) | Substituierte chinoline für die behandlung von leismaniosen | |
| DE69929689D1 (de) | Heterozyclische derivate für die behandlung von herzversagen und andere erkrankungen | |
| HUP9900120A2 (hu) | Benzoszulfonszármazékok, eljárás előállításukra, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmény | |
| YU89691A (sh) | Postupak za dobijanje stereoselektivnih derivata fenilizoserina | |
| TR199802253T2 (xx) | Alkilaminobenzotiazol ve benzoksazol t�revleri | |
| DE69525327D1 (de) | Anthracyclin-derivate | |
| ES455741A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol. | |
| SU1568887A3 (ru) | Cпocoб пoлучehия пипepaзиhcoдepжaщиx углeboдopoдob или иx kиcлotho-aддиtиbhыx coлeй | |
| DE69715230D1 (de) | Bis(acridinecarboxamide) und bis(phenazinecarboxamide) als antikrebsmittel | |
| ES451484A1 (es) | Procedimiento para la obtencion de derivados de n-(1, 2, 4- triacin-5, on-4-il)oliuna. | |
| DK0435235T3 (da) | Nye isoquinolinderivater og salte deraf | |
| FR2684992B1 (fr) | Procede de preparation d'amino-2 nitro-7 benzothiazoles. | |
| FR2695643B1 (fr) | Dérivés d'uréido-acétamide, leur préparation et les médicaments les contenant. | |
| ATE136029T1 (de) | Carbostyrylderivate | |
| ES8400849A1 (es) | Procedimiento para la obtencion de oximinoacetanilidas sustituidas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |